Back to Search

Alekshun, Todd Joseph, MD

Title
Chief, Hematology/Oncology, Hartford Hospital

Gender

Male


Language

English

Providing the best care to our patients and their companions requires communicating in a way everyone understands. Interpreter services are available 24 hours a day, 7 days a week, 365 days a year. All spoken languages are available, as well as American Sign Language (AS/L).


Specialties
Accepting New Patients
  • Hematology / Oncology
  • Medical Oncology

Areas of Expertise
Colorectal Cancer, Gastrointestinal Cancer, Lung Cancer, Lymphoma, Myelomas, Thoracic Cancers

Hospitals and Organizations

  • Hartford HealthCare Medical Group
  • Integrated Care Partners
  • Hartford Hospital
  • Charlotte Hungerford Hospital

Education

Fellowship
H. H. Lee Moffitt Cancer Center ‐ Hematology/Oncology, Blood & Marrow Transplant

Medical School
St George's University School of Medicine

Residency
University of Connecticut School of Medicine


Professional Organizations

  • American Society of Clinical Oncology
  • American Society of Hematology
  • Kappa Psi Pharmaceutical Fraternity

Bio

Todd J. Alekshun, MD, RPh, is a hematologist/oncologist at Hartford Hospital. He is a graduate of the St. George’s University School of Medicine in Grenada, then completed internal medicine residency at Hartford Hospital through UConn and a fellowship in hematology/oncology at the University of South Florida. He also holds a degree in pharmacy from UConn.

Dr. Alekshun conducts a variety of research, and served as the principal investigator on a clinical trial investigating the use of a combination of medications to condition patients with primary refractory multiple myeloma and plasma cell leukemia for blood stem cell transplants. He also served as principal investigator of a study into the use of medication treatment for high-risk patients with multiple myeloma.

He has also published in professional journals on such subjects as diseases of large granular lymphocytes, aggressive t-cell large granular lymphocyte leukemia and skeletal muscle T-cell lymphoma.

News

Loading...